181 related articles for article (PubMed ID: 37036164)
41. CD4
Pan Y; Wang H; An F; Wu F; Tao Q; Li Y; Ruan Y; Zhai Z
Int Immunopharmacol; 2021 Jul; 96():107742. PubMed ID: 33984717
[TBL] [Abstract][Full Text] [Related]
42. [CART therapy followed by allo-HSCT for patients with B-cell acute lymphoblastic leukemia relapsing after the first hematopoietic stem cell transplantation].
Cao XY; Qiu LY; Zhang JP; Xiong M; Zhao YL; Lu Y; Zhou JR; Wei ZJ; Sun RJ; Liu DY; Zhang X; Yang JF; Lu PH
Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):318-323. PubMed ID: 33979977
[No Abstract] [Full Text] [Related]
43. How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.
Frey NV; Luger SM
Blood; 2015 Jul; 126(5):589-96. PubMed ID: 25966988
[TBL] [Abstract][Full Text] [Related]
44. Donor CD7 Chimeric Antigen Receptor T Cell Bridging to Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Hematologic Malignancy.
Li Z; An N; Yang K; Meng F; Xu T; Peng X; Wen X; Li J; Song Y; Yang R; Wu T
Transplant Cell Ther; 2023 Mar; 29(3):167-173. PubMed ID: 36427783
[TBL] [Abstract][Full Text] [Related]
45. The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experience.
Dyakonova YY; Bydanov OI; Popov AM; Olshanskaya YV; Boichenko EG; Aleynikova OV; Maschan MA; Shelikhova LN; Litvinov DV; Khachatryan LA; Ponomareva NI; Fechina LG; Novichkova GA; Pashanov ED; Karachunskiy AI
Ter Arkh; 2018 Aug; 90(7):38-50. PubMed ID: 30701921
[TBL] [Abstract][Full Text] [Related]
46. CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany.
Bader P; Rossig C; Hutter M; Ayuk FA; Baldus CD; Bücklein VL; Bonig H; Cario G; Einsele H; Holtick U; Koenecke C; Bakhtiar S; Künkele A; Meisel R; Müller F; Müller I; Penack O; Rettinger E; Sauer MG; Schlegel PG; Soerensen J; von Stackelberg A; Strahm B; Hauer J; Feuchtinger T; Jarisch A
Blood Adv; 2023 Jun; 7(11):2436-2448. PubMed ID: 36607834
[TBL] [Abstract][Full Text] [Related]
47. [Maintenance therapy following CD19 CAR-T treatment for relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
Jiang YL; Li Q; Pu YD; Jiang YY; Yuan T; Deng Q; Li YM; Han MZ; Zhai WH
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):495-501. PubMed ID: 32654464
[No Abstract] [Full Text] [Related]
48. Low Frequency of ETV6-RUNX1 (t 12; 21) in Saudi Arabian Pediatric Acute Lymphoblastic Leukemia Patients: Association with Clinical Parameters and Early Remission.
Aljamaan K; Aljumah TK; Aloraibi S; Absar M; Iqbal Z
Asian Pac J Cancer Prev; 2015; 16(17):7523-7. PubMed ID: 26625756
[TBL] [Abstract][Full Text] [Related]
49. Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing.
Jin Y; Wang X; Hu S; Tang J; Li B; Chai Y
Cancer Med; 2016 Feb; 5(2):337-51. PubMed ID: 26711002
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic strategies, including allogeneic stem cell transplantation, to overcome relapsed/refractory adult T-cell acute lymphoblastic leukemia.
Baek DW; Lee JM; Kim J; Cho HJ; Moon JH; Sohn SK
Expert Rev Hematol; 2021 Aug; 14(8):765-775. PubMed ID: 34313508
[TBL] [Abstract][Full Text] [Related]
51. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
Skálová A; Banečkova M; Thompson LDR; Ptáková N; Stevens TM; Brcic L; Hyrcza M; Michal M; Simpson RHW; Santana T; Michal M; Vaněček T; Leivo I
Am J Surg Pathol; 2020 Oct; 44(10):1295-1307. PubMed ID: 32675658
[TBL] [Abstract][Full Text] [Related]
52. T cell exhaustion characterized by compromised MHC class I and II restricted cytotoxic activity associates with acute B lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation.
Liu L; Chang YJ; Xu LP; Zhang XH; Wang Y; Liu KY; Huang XJ
Clin Immunol; 2018 May; 190():32-40. PubMed ID: 29477343
[TBL] [Abstract][Full Text] [Related]
53. SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric
Serafin V; Porcù E; Cortese G; Mariotto E; Veltri G; Bresolin S; Basso G; Accordi B
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817853
[TBL] [Abstract][Full Text] [Related]
54. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.
Zaliova M; Kotrova M; Bresolin S; Stuchly J; Stary J; Hrusak O; Te Kronnie G; Trka J; Zuna J; Vaskova M
Genes Chromosomes Cancer; 2017 Aug; 56(8):608-616. PubMed ID: 28395118
[TBL] [Abstract][Full Text] [Related]
55. Allogeneic Hematopoietic Stem Cell Transplantation for Adult Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Second Complete Remission.
Kaito S; Kurosawa S; Najima Y; Sakaida E; Shingai N; Fukuda T; Tachibana T; Uchida N; Ozawa Y; Sawa M; Nakazawa H; Ota S; Kato J; Nakamae H; Katayama Y; Eto T; Tanaka J; Kanda Y; Atsuta Y; Arai Y; Kako S;
Transplant Cell Ther; 2022 Jun; 28(6):326.e1-326.e10. PubMed ID: 35306218
[TBL] [Abstract][Full Text] [Related]
56. Novel cryptic, complex rearrangements involving ETV6-CBFA2 (TEL-AML1) genes identified by fluorescence in situ hybridization in pediatric patients with acute lymphoblastic leukemia.
Mathew S; Shurtleff SA; Raimondi SC
Genes Chromosomes Cancer; 2001 Oct; 32(2):188-93. PubMed ID: 11550288
[TBL] [Abstract][Full Text] [Related]
57. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
[TBL] [Abstract][Full Text] [Related]
58. Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant.
Li Q; Lyu C; Liu M; Wang J; Mou N; Jiang E; Zhang R; Deng Q
Cell Transplant; 2023; 32():9636897231158155. PubMed ID: 36879459
[TBL] [Abstract][Full Text] [Related]
59. ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations.
Strehl S; Nebral K; König M; Harbott J; Strobl H; Ratei R; Struski S; Bielorai B; Lessard M; Zimmermann M; Haas OA; Izraeli S
Clin Cancer Res; 2008 Feb; 14(4):977-83. PubMed ID: 18281529
[TBL] [Abstract][Full Text] [Related]
60. Ponatinib therapy in recurrent Philadelphia chromosome-positive central nervous system leukemia with T315I mutation after Allo-HSCT.
He JB; Zhang X; Guo ZW; Liu MM; Xu N; Huang F; Fan ZP; Xuan L; Deng L; Lin SH; Xu J; Sun J; Liu QF
Int J Cancer; 2020 Aug; 147(4):1071-1077. PubMed ID: 31785158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
